Comparison between Modern Diagnostic IPO and Oremet Alloys IPO.
Modern Diagnostic IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Oremet Alloys IPO is a SME Bookbuilding proposed to list at BSE SME.
| Modern Diagnostic IPO | Oremet Alloys IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Sobhagya Capital Options Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Modern Diagnostic IPO is up to ₹35.04 Cr whereas the issue size of the Oremet Alloys IPO is up to ₹0.00 Cr. The final issue price of Modern Diagnostic IPO is ₹90.00 per share and of Oremet Alloys IPO is .
| Modern Diagnostic IPO | Oremet Alloys IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹85.00 per share | |
| Issue Price (Upper) | ₹90.00 per share | |
| Issue Price (Final) | ₹90.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | |
| Fresh Issue Size | 38,92,800 shares | 44,26,800 shares |
| Fresh Issue Size (Amount) | up to ₹35.04 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 38,92,800 shares | 44,26,800 shares |
| Issue Size Total (Amount) | up to ₹35.04 Cr | up to ₹0.00 Cr |
Modern Diagnostic IPO opens on Dec 31, 2025, while Oremet Alloys IPO opens on . The closing date of Modern Diagnostic IPO and Oremet Alloys IPO is Jan 02, 2026, and , respectively.
| Modern Diagnostic IPO | Oremet Alloys IPO | |
|---|---|---|
| Anchor Bid Date | Dec 30, 2025 | |
| Issue Open | Dec 31, 2025 | |
| Issue Close | Jan 02, 2026 | |
| Basis Of Allotment (Tentative) | Jan 05, 2026 | |
| Initiation of Refunds (Tentative) | Jan 06, 2026 | |
| Credit of Share (Tentative) | Jan 06, 2026 | |
| Listing date (Tentative) | Jan 07, 2026 | |
| Anchor Lockin End date 1 | Feb 03, 2026 | |
| Anchor Lockin End date 2 | Apr 04, 2026 |
Modern Diagnostic IPO P/E ratio is 11.04, as compared to Oremet Alloys IPO P/E ratio of .
| Modern Diagnostic IPO | Oremet Alloys IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Modern Diagnostic & Research Centre Ltd.'s revenue increased by 15% and profit after tax (PAT) rose by 55% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Oremet Alloys & Castings Ltd.'s revenue decreased by 22% and profit after tax (PAT) rose by 52% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.99 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹135.89 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 55.21 | 69.81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.18 | 61.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.07 | 0.17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 43.27 | 69.81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Modern Diagnostic IPO Retail Individual Investors (RII) are offered 13,63,200 shares while in Oremet Alloys IPO retail investors are offered 13,63,200 shares. Qualified Institutional Buyers (QIB) are offered 7,82,400 shares in Modern Diagnostic IPO and in Oremet Alloys IPO.
| Modern Diagnostic IPO | Oremet Alloys IPO | |
|---|---|---|
| Anchor Investor Reservation | 11,61,600 shares | |
| Market Maker Reservation | 2,06,400 shares | |
| QIB | 7,82,400 shares | |
| NII | 5,85,600 shares | |
| RII | 13,63,200 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 38,92,800 shares |
Modern Diagnostic IPO subscribed 376.90x in total, whereas Oremet Alloys IPO subscribed .
| Modern Diagnostic IPO | Oremet Alloys IPO | |
|---|---|---|
| QIB (times) | 193.51x | |
| NII (times) | 702.08x | |
| Big NII (times) | 855.83x | |
| Small NII (times) | 386.91x | |
| RII (times) | 342.46x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 376.90x |
